Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes - PubMed (original) (raw)

Affiliations

PMID: 2657579

Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes

M Lübbert et al. Oncogene. 1989 May.

Abstract

p53 is a nuclear protein associated with cellular transformation and normal cellular proliferation. Some transformed cells have been found to have one or several quantitative or qualitative abnormalities of p53. We studied expression, kinetics, phosphorylation, DNA methylation and chromatin structure of p53 in resting and proliferating untransformed T-lymphocytes and in human T-cell leukemia virus type I transformed T-lymphocytes from the same individuals. p53 expression is indistinguishable in transformed compared to untransformed proliferating T-lymphocytes by: (1) p53 mRNA levels, (2) rate of synthesis and stability of p53 protein, (3) change in protein stability after exposure to an inhibitor of protein synthesis, (4) presence of phosphorylation of the p53 protein. Resting T-lymphocytes from these same individuals did not express p53. No difference in DNA methylation and chromatin structure of the p53 gene was observed in either resting or proliferating untransformed, or virally transformed T-lymphocytes. The gene was fully methylated and resistant to DNAase I over its entire coding region but was demethylated and contained DNAase I hypersensitive sites in a distinct region 5' of the site of initiation of transcription.

PubMed Disclaimer

Cited by

Compilation of vertebrate-encoded transcription factors.
Faisst S, Meyer S. Faisst S, et al. Nucleic Acids Res. 1992 Jan 11;20(1):3-26. doi: 10.1093/nar/20.1.3. Nucleic Acids Res. 1992. PMID: 1738600 Free PMC article. No abstract available.
P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.
Gupta S. Gupta S. Drugs Aging. 1995 Jul;7(1):19-29. doi: 10.2165/00002512-199507010-00003. Drugs Aging. 1995. PMID: 7579778 Review.
Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.
Gartenhaus RB, Wang P, Hoffmann P. Gartenhaus RB, et al. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):265-8. doi: 10.1073/pnas.93.1.265. Proc Natl Acad Sci U S A. 1996. PMID: 8552618 Free PMC article.
Control of G1 arrest after DNA damage.
Kastan MB, Kuerbitz SJ. Kastan MB, et al. Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):55-8. doi: 10.1289/ehp.93101s555. Environ Health Perspect. 1993. PMID: 8013425 Free PMC article. Review.
Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
Yamato K, Oka T, Hiroi M, Iwahara Y, Sugito S, Tsuchida N, Miyoshi I. Yamato K, et al. Jpn J Cancer Res. 1993 Jan;84(1):4-8. doi: 10.1111/j.1349-7006.1993.tb02775.x. Jpn J Cancer Res. 1993. PMID: 8449826 Free PMC article.

Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes - PubMed (original) (raw)